6-Fluoro-2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 97%, 250mg

1,3,6,8-Tetrakis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrene, 97%, 10g

Sample reservoir Liqui, 500 ml, PTFE, FEP, 1 piece

3,4-Dihydro-1,7-naphthyridin-2(1H)-one, 98%, 1g

((3-Chloropropoxy)methyl)benzene, 95.0%, 1g

tert-butyl 3-azidoazetidine-1-carboxylate, 95.0%, 250mg

6-(3-Methoxyphenyl)nicotinaldehyde, 95%, 1g

2-(2-(Cyclopropylmethoxy)-5-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95+%, 100mg

Methyl 3,4,5-tris(benzyloxy)benzoate, 98%, 100g

N-(2-METHYLPHENYLMETHYL)ISOPROPYLAMINE, 97%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-iodophenyl)propanoic acid, 95%, 250mg

1,2,3-Trichloropropene (cis- and trans- mixture)>95.0%(GC)25g

1,3-Dimethyl-1H-indazol-5-amine, 95.0%, 250mg